PARP1通过调节METTL3-介导的 TRAIL m6A甲基化来促进内增生
Shaodong Li1, Fengxiang Pang2, Wenhai Guo2
1Department of Traditional Chinese Medicine, The Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, Guangdong, China. Glsd6300@163.com.
Cell biology and toxicology
|October 16, 2025
概括
PARP1 抑制剂 PJ34 通过向 TRAIL 的 METTL3 介导的 m6A 甲基化来减少血管内皮增生. 这种表观遗传方法为治疗血管重塑疾病提供了新的策略.
科学领域:
- 心血管生物学 心血管生物学
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
- 分子医学是分子医学.
背景情况:
- 聚 (ADP-ribose) 聚合酶1 (PARP1) 与血管内皮增生 (IH) 和N6-甲基氨酸 (m6A) 甲基化有关.
- 了解PARP1,m6A和IH之间的相互作用对于开发新的治疗策略至关重要.
研究的目的:
- 研究PARP1抑制剂PJ34是否可以通过调节m6A甲基化来改善血管IH.
- 阐明涉及甲基转移酶类3 (METTL3) 和瘤亡因子相关的亡诱导配体 (TRAIL) 的潜在分子机制.
主要方法:
- 小鼠经历了大腿动脉电线损伤以诱导IH;血管光滑肌细胞 (VSMC) 受到PDGF-BB的挑战.
- 用PJ34,METTL3过度表达/缺陷,TRAIL淘汰和分子测试 (点点,RT-qPCR,西点,免疫组织化学) 的治疗.
主要成果:
- PJ34治疗显著降低了新阴极形成,VSMC增殖和受伤动脉的全球m6A水平.
- PJ34抑制了PDGF-BB诱导的VSMC扩散和迁移,这种效应依赖METTL3并通过METTL3-依赖的m6A修饰通过TRAIL的下调调节来调节.
- 通过TRAIL的淘汰,小鼠对PJ34的保护作用产生了耐药性,证实了TRAIL在不诱导全身炎症的情况下发挥的关键下游作用.
结论:
- 通过抑制METTL3介导的TRAIL mRNA m6A甲基化,PJ34减轻了血管IH的作用.
- 这项研究揭示了调节血管重塑的新型表观遗传机制,并建议PJ34作为IH的潜在治疗剂.
相关概念视频
PI3K/mTOR/AKT Signaling Pathway
5.3K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
5.3K
mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K
Abnormal Proliferation
5.1K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.1K
Long-patch Base Excision Repair
7.8K
Since the discovery of the two BER pathways, there has been a debate about how a cell chooses one pathway over the other and the factors determining this selection. Numerous in vitro experiments have pointed out multiple determinants for the sub-pathway selection. These are:
7.8K
Interactions Between Signaling Pathways
7.2K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.2K
MAPK Signaling Cascades
7.9K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
7.9K


